Biocon Biologics Inc. NDC Codes

Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

Drugs

Yesintek, Adalimumab, Ogivri, Kirsty, Jobevne, Hulio, Semglee, Insulin Glargine, Yesafili, Bosaya, Aukelso, INSULIN DILUTING MEDIUM FOR Kirsty, Fulphila

Active ingredients

Ustekinumab, Insulin glargine, Denosumab, Insulin aspart, Bevacizumab, Trastuzumab, Aflibercept, Water, Pegfilgrastim

NDC labeler codes

83257

Strengths

Insulin glargine 100 [iU]/mL; Insulin aspart 100 [iU]/mL; Bevacizumab 25 mg/mL; Ustekinumab 45 mg/.5mL; Aflibercept 2 mg/.05mL; Denosumab 60 mg/mL; Denosumab 120 mg/1.7mL; Water 1 mL/mL; Ustekinumab 90 mg/mL; Ustekinumab 130 mg/26mL; Trastuzumab 150 mg/7.4mL; Trastuzumab 420 mg/20mL; Pegfilgrastim 6 mg/.6mL

Dosage forms

Injection, Solution, Kit, Injection, Injection, Powder, Lyophilized, For solution, Solution

Routes

Subcutaneous, Intravenous, Intravascular, Intravitreal

Drug classes (FDA established)

Insulin Analog, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Vascular Endothelial Growth Factor Inhibitor, RANK Ligand Inhibitor, HER2/neu Receptor Antagonist, Leukocyte Growth Factor

HCPCS / J-code

J0178 — Injection, aflibercept, 1 mg, J0897 — Injection, denosumab, 1 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J9355 — Injection, trastuzumab, excludes biosimilar, 10 mg, J2506 — Injection, pegfilgrastim, excludes biosimilar, 0.5 mg

Package NDCs

26

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Biocon Biologics Inc.: common questions

What is Biocon Biologics Inc.'s NDC labeler code?

83257. The labeler code is the first segment of each NDC. About labeler codes.

Is there a J-code for Biocon Biologics Inc.?

Med-Code's HCPCS directory matches J0178, J0897, J3357, J9355, J2506 to these products. NDC vs J-code.

Which NDC goes on a claim?

The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.